Is COGT undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -11.24 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.29 USD, the upside of Cogent Biosciences Inc is -254.14%. This means that COGT is overvalued by 254.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.24 - -11.24 | -11.24 | -254.14% |
| P/E | (70.57) - (109.13) | (85.40) | -1271.4% |
| DDM - Stable | (23.31) - (77.04) | (50.18) | -788.3% |
| DDM - Multi | (15.72) - (40.81) | (22.75) | -412.1% |
| Market Cap (mil) | 829.97 |
| Beta | 0.39 |
| Outstanding shares (mil) | 113.85 |
| Enterprise Value (mil) | 731.80 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.69% |
| Cost of Debt | 5.00% |
| WACC | 6.18% |